PROF
Profound Medical Corp.Company with tickers: PROF
CIK
1628808
CUSIP
74319B502
Shares Outstanding
36,337,637
13F Activity (30d)
50 filings
49 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $5,337,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $1,505,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Gross Profit | $3,832,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | $11,853,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $5,262,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-8,021,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-7,053,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $0.19 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $0.19 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |